Publications


HER2-positive breast cancer in patients with BRCA1/2 pathogenic variants: Case series and literature review;
Munnangi, P, Niravath, PA, Chang, JC & Sun, K 2025, , Current Problems in Cancer: Case Reports, vol. 17, 100335. https://doi.org/10.1016/j.cpccr.2024.100335

Application of validated size-exclusion chromatography method for physicochemical characterization of topical gel formulation of deferoxamine conjugated with PEGylated carbon nanoparticles;
Khan, AA, Mohamed, EM, Kashif Iqubal, M, Tour, JM, McHugh, EA, Chang, DF, Cooke, JP, Rahman, Z & Kent, TA 2024, , International Journal of Pharmaceutics, vol. 666, 124834. https://doi.org/10.1016/j.ijpharm.2024.124834

EphrinB2-mediated CDK5/ISL1 pathway enhances cardiac lymphangiogenesis and alleviates ischemic injury by resolving post-MI inflammation;
Bai, Y, Chen, L, Guo, F, Zhang, J, Hu, J, Tao, X, Lu, Q, Li, W, Chen, X, Gong, T, Qiu, N, Jin, Y, Yang, L, Lei, Y, Ruan, C, Jing, Q, Cooke, JP, Wang, S, Zou, Y & Ge, J 2024, , Signal Transduction and Targeted Therapy, vol. 9, no. 1, 326, pp. 326. https://doi.org/10.1038/s41392-024-02019-4

Outcomes of Patients with Hepatocellular Carcinoma Undergoing Liver Transplantation Utilizing Extended Criteria Donor Grafts;
Brombosz, EW, Hobeika, MJ, Kodali, S, Connor, AA, Saharia, A, Mobley, CM, Simon, CJ, Cheah, YL, Abdelrahim, M, Victor, III, DW, Graviss, EA, Nguyen, DT, Moore, LW & Ghobrial, RM 2024, , Transplantation Proceedings, vol. 56, no. 10, pp. 2203-2212. https://doi.org/10.1016/j.transproceed.2024.10.039

Translational modeling-based evidence for enhanced efficacy of standard-of-care drugs in combination with anti-microRNA-155 in non-small-cell lung cancer;
Dogra, P, Shinglot, V, Ruiz-Ramírez, J, Cave, J, Butner, JD, Schiavone, C, Duda, DG, Kaseb, AO, Chung, C, Koay, EJ, Cristini, V, Ozpolat, B, Calin, GA & Wang, Z 2024, , Molecular Cancer, vol. 23, no. 1, 156. https://doi.org/10.1186/s12943-024-02060-5

Chapter 24 - Patient characteristics and evaluations prior to liver transplantation;
Abdelrahim, M, Alqahtani, A, Esmail, A & Al-Judaibi, B 2024, . in MA Abdelrahim (ed.), Transplant Oncology. Academic Press, pp. 277-293. https://doi.org/10.1016/B978-0-443-21901-6.00024-0

Metabolic targeting of cancer associated fibroblasts overcomes T-cell exclusion and chemoresistance in soft-tissue sarcomas;
Broz, MT, Ko, EY, Ishaya, K, Xiao, J, De Simone, M, Hoi, XP, Piras, R, Gala, B, Tessaro, FHG, Karlstaedt, A, Orsulic, S, Lund, AW, Chan, KS & Guarnerio, J 2024, , Nature Communications, vol. 15, no. 1, 2498. https://doi.org/10.1038/s41467-024-46504-4

Functional diversity and regulation of IL-9-producing T cells in cancer immunotherapy;
Kalim, M, Jing, R, Guo, W, Xing, H & Lu, Y 2024, , Cancer Letters, vol. 606, 217306. https://doi.org/10.1016/j.canlet.2024.217306

Chapter 18 - History of cancer and transplant clearance: Considerations prior to transplantation;
Esmail, A & Abdelrahim, M 2024, . in MA Abdelrahim (ed.), Transplant Oncology. Academic Press, pp. 215-228. https://doi.org/10.1016/B978-0-443-21901-6.00018-5